Form 4: VolitionRx Director Alan Colman Receives Restricted Stock Units in Lieu of Cash Compensation

Director Alan Colman of VolitionRx Ltd. received 13,757 restricted stock units (RSUs) on September 1, 2024, in lieu of cash compensation.

Summary

• On September 1, 2024, Alan Colman, a director of VolitionRx Ltd., was granted 13,757 restricted stock units (RSUs) as compensation.
• These RSUs were awarded under the company's 2015 Stock Incentive Plan.
• The RSUs will vest in three installments on September 1, 2024, October 1, 2024, and November 1, 2024, with a final vesting date of June 1, 2025, subject to continued service.
• Upon vesting, Colman will receive common stock shares equal to the number of vested RSUs, increasing his holdings to 217,552 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and aligns the director's interests with shareholders. There are no explicit negative implications.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Granting stock-based compensation to directors is a common practice to align their interests with those of shareholders and incentivize long-term value creation. This is a standard method of compensation in the biotechnology industry.

Comparison to Industry Standards

• Stock-based compensation for board members is a common practice across various industries, particularly in growth-oriented sectors like biotechnology.
• Companies like Exact Sciences and Guardant Health also utilize stock options and RSUs as part of their director compensation packages.
• The vesting schedules and amounts of equity granted can vary significantly based on company size, performance, and individual contributions.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.
• The director is incentivized to contribute to the company's growth and profitability.

Next Steps

• Colman will receive shares of common stock as the RSUs vest according to the specified schedule.

Key Dates